// App-Quantinova.ai

POS0319 (2021) : PERFORMANCE OF PATIENT REPORTED OUTCOMES (PROs) IN SCLERODERMA PATIENTS WITH REDUCED LUNG FUNCTION IN AN OBSERVATIONAL COHORT

Researchers

Presenter

  • M. G. Lazzaroni

Principal Investigators

  • G. Abignano

  • M. Wilson

  • V. Kakkar

  • F. Del Galdo

Medical Centers

  • Spedali Civili and University of Brescia, Rheumatology and Clinical Immunology Unit, Brescia, Italy

  • University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine and Biomedical Research Centre, Leeds, United Kingdom

  • Azienda Ospedaliera San Carlo, Rheumatology, Potenza, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

Outcome

  • N/A

Study Design

  • Observational

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Boehringer Ingelheim

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved